Showing results (541-550 of 885) with videos related to
Sort By:
Pageof 89
Vaccine|May 1, 2012
Intradermally administered TLR4 agonist GLA-SE enhances the capacity of human skin DCs to activate T cells and promotes emigration of Langerhans cellsLaura P Schneider, Antoinet J Schoonderwoerd, Magdalini Moutaftsi, et al.Clinical and Vaccine Immunology : CVI|December 15, 2015
Protection and Long-Lived Immunity Induced by the ID93/GLA-SE Vaccine Candidate against a Clinical Mycobacterium tuberculosis IsolateSusan L Baldwin, Valerie A Reese, Po-Wei D Huang, et al.Vaccine|September 10, 2013
Immunisation with ID83 fusion protein induces antigen-specific cell mediated and humoral immune responses in cattleGareth J Jones, Sabine Steinbach, Derek Clifford, et al.Journal of Acquired Immune Deficiency Syndromes|January 1, 1992
Cytokine activation of human macrophages infected with HIV-1 to inhibit intracellular protozoaS G Reed, J S da Silva, J L Ho, et al.Infection and Immunity|August 23, 2005
Tracking antigen-specific CD8 T lymphocytes in the lungs of mice vaccinated with the Mtb72F polyproteinScott M Irwin, Angelo A Izzo, Steven W Dow, et al.Journal of Lipid Research|February 28, 2002
Apolipoprotein [a] genotype influences isoform dominance pattern differently in African Americans and CaucasiansJill Rubin, Furcy Paultre, Catherine H Tuck, et al.Vaccine|October 15, 2013
TLR4 ligand formulation causes distinct effects on antigen-specific cell-mediated and humoral immune responsesChristopher B Fox, Magdalini Moutaftsi, Julie Vergara, et al.European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|November 20, 2014
Specific antibody responses as indicators of treatment efficacy for visceral leishmaniasisA C Vallur, A Hailu, D Mondal, et al.Clinical and Diagnostic Laboratory Immunology|September 8, 1998
rK39 enzyme-linked immunosorbent assay for diagnosis of Leishmania donovani infectionE E Zijlstra, N S Daifalla, P A Kager, et al.Proceedings of the National Academy of Sciences of the United States of America|October 10, 2012
Adjuvant solution for pandemic influenza vaccine productionChristopher H Clegg, Richard Roque, Neal Van Hoeven, et al.Pageof 89